Nuvation Bio (NUVB) Gains from Investment Securities (2023 - 2025)
Historic Gains from Investment Securities for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to -$612000.0.
- Nuvation Bio's Gains from Investment Securities fell 1482.18% to -$612000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.4 million, marking a year-over-year increase of 413588.52%. This contributed to the annual value of $6.0 million for FY2024, which is 39580.59% up from last year.
- Nuvation Bio's Gains from Investment Securities amounted to -$612000.0 in Q3 2025, which was down 1482.18% from -$454000.0 recorded in Q2 2025.
- In the past 5 years, Nuvation Bio's Gains from Investment Securities registered a high of $5.8 million during Q4 2024, and its lowest value of -$1.1 million during Q2 2024.
- Moreover, its 3-year median value for Gains from Investment Securities was -$262500.0 (2023), whereas its average is $796600.0.
- Data for Nuvation Bio's Gains from Investment Securities shows a peak YoY increase of 112746.48% (in 2024) and a maximum YoY decrease of 52830.19% (in 2024) over the last 5 years.
- Over the past 3 years, Nuvation Bio's Gains from Investment Securities (Quarter) stood at -$383000.0 in 2023, then soared by 1618.54% to $5.8 million in 2024, then plummeted by 110.52% to -$612000.0 in 2025.
- Its last three reported values are -$612000.0 in Q3 2025, -$454000.0 for Q2 2025, and $3.7 million during Q1 2025.